Search:
Computing and Library Services - delivering an inspiring information environment

Pharmacological treatment of depression in older people

Curran, Stephen, Byrne, Andrew and Wattis, John (2006) Pharmacological treatment of depression in older people. Mental Health and Learning Disabilities Research and Practice, 3 (1). pp. 63-85. ISSN 1743-6885

[img]
Preview
PDF
316.pdf

Download (425kB) | Preview

Abstract

In the light of recent National Institute for Clinical Excellence (NICE) and Committee for the Safety of Medicines (CSM) guidance we discuss the importance of the diagnosis of depression in old age and review pharmacological interventions. An introductory section is followed by sections on each of the main antidepressant groups. This briefly describes their pharmacology and reviews research done specifically relevant to older people. Finally practical clinical applications are discussed.

▼ Jump to Download Statistics
Item Type: Article
Uncontrolled Keywords: pharmacological treatment; depression; older elderly people
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Schools: School of Human and Health Sciences
School of Human and Health Sciences > Ageing and Mental Health Research Group
Related URLs:
References:

Abou-Saleh, M.T. & Coppen A. 1983. The prognosis of depression in old
age: the case for lithium therapy. British Journal of Psychiatry,; 170, 285-
287.
Aguglia, E. 2000. Reboxetine in the maintenance therapy of depressive
disorder in the elderly: a long-term open study International Journal of
Geriatric Psychiatry, 15, 784-93..
Akiskal, H.S. 1985. An approach to chronic and ‘resistant’ depressions:
evaluation and treatment. Journal of Clinical Psychiatry,; 46, 32-36.
Alexopoulous, G.S. 1992. Geriatric depression reaches maturity.
International Journal of Geriatric Psychiatry, 7, 305-306.
Ames, D., Ashby, D., Mann, A.H. & Graham, N. 1988. Psychiatric illness in
elderly residents of part 3 homes in one London borough: prognosis and
review. Age and Ageing, 17(4), 249-256.
Anderson, I. & Edwards, J. 2001. Guidelines for choice of selective
serotonin reuptake inhibitor in depressive illness. Advances in Psychiatric
Treatment,, 7, 170-180.
Anderson, I.M., Nutt, D.J., & Deakin, J.F.W. 2000. Evidence-based
guidelines for treating depressive disorders with antidepressants; a revision
of the 1993 British Association for Psychopharmacology guidelines. Journal
of Psychopharmacology, 14(1), 3-20.
Anderson, I.M. 2001. Meta-analytical studies on new antidepressants.
British Medical Bulletin, 1, 161-178.
Angst, J. 1997. A regular review of long term follow-up of depression.
British Medical Journal, 315, 1143-1146.
Appelberg, B. 2002. Long-term citalopram prevents recurrent depression in
the elderly and is well tolerated. Evidence Based Mental Health, 6(1):24.
Ariyo, A.A., Haan, M., Tangen, C.M. et al. 2000. Depressive symptoms and
risks of coronary heart disease and mortality in elderly Americans.
Circulation, 102, 1773-1779.
Aronson, R., Offman, H.J., Joffe R.T. & Naylor, C.D. 1996. Triiodothyronine
augmentation in the treatment of refractory depression. A meta-analysis.
Archives of General Psychiatry, 53, 842-848.
Austin, M.P.V., Souza, F.G.M. & Goodwin, G.M. 1991. Lithium
augmentation in antidepressant-resistant patients: a quantitative analysis.
British Journal of Psychiatry,159, 510-14.
Baldwin, R.C. 1996. Treatment resistant depression in the elderly: a review
of treatment options. Reviews in Clinical Gerontology, 6, 343-348.Baldwin, R.C., Chiu, E, Katona, C, & Grahaam, N. 2002. Guidelines on
Depression in Older People: practising the evidence. Martin Dunitz,
London.
Barak, Y., Swartz, M., Levy, D. et al. 2003. Age-related differences in the
side-effect profile of citalopram. Progress in Neuropsychopharmacology
and Biological Psychiatry, 27(3), 545-548.
Barbui, C. & Hotopf, M. 2001. Amitriptyline versus the rest; still the leading
antidepressant after 40 years of randomised controlled trials. British Journal
of Psychiatry, 178, 129-144.
Baumann, P. 1998. Care of depression in the elderly: comparative
pharmacokinetics of SSRIs. International Clinical Psychopharmacology, 13
(suppl.5), 35-43.
N. F. N. Bergmann, J.F., Laneury, J.P., Duchene, P., Fleishaker, J.C.,
Houin, G & Segrestaa, J.M. 2000. Pharmacokinetics of reboxetine in
healthy, elderly volunteers. European Journal of Drug Metabolism &
Pharmacokinetics, 25(3-4), 195-198.
Bielski, R., Ventura, D. & Chung-Chi C. 2003. A double-blind comparison of
escitalopram with venlafaxine XR in the treatment of major depressive
disorder. 16th Congress of the European College of
Neuropsychopharmacology, Prague, 20-24, September 2003.
Bodani, M. Sheehan, B. & Philpot M. 1999. The use of dexamethasone in
elderly patients with antidepressant–resistant depressive illness. Journal of
Psychopharmacology, 13(2), 196-197.
Bonnet, U. 2003. Moclobemide; therapeutic use and clinical studies. CNS
Drug Reviews, 9(1), 97-140.
Bowskill, R.J. & Bridges, P.L. 1997. Treatment-resistant affective disorders.
British Journal of Hospital Medicine, 57, 171-172.
Committee on Safety of Medicines 2004. Report of the CSM Expert
Working Group on the Safety of Selective Serotonin reuptake Inhibitors
Antidepressants, December 2004, www.mhra.gov.uk
Committee on Safety of Medicines 2004. Safety of Selective Serotonin
Reuptake Inhibitor Antidepressants. www.mhra.gov.uk
Cowen, P.J. 1998. Pharmacological management of treatment-resistant
depression. Advances in Psychiatric Treatment,,4, 320-327.
Cujpers, P. 1998. Psychological outreach programmes for the depressed
elderly: A meta-analysis of effects and dropout. International Journal of
Geriatric Psychiatry, 13(1), 41-48.
Curran, S. 1995. Effect of paroxetine on seizure length during
electroconvulsive therapy. Acta Psychiatrica Scandinavica, 12(2), 239-240.Curran, S. & Wattis, J.P. 2004. Psychopharmacology in the elderly. In:
Seminars in Clinical Psychopharmacology (Ed. D.J King), 2nd Edition,
Gaskell, London, 447-484.
Curran, S, Nightingale, S. & Wattis, J.P. 2005. Practical issues in assessing
and prescribing psychotropic drugs in older people. In: Practical Old Age
Psychopharmacology; A Multi-Professional Approach, S Curran and R
Bullock (Eds.), Radcliffe Medical, Oxford, 47-72.
Danjou, P. & Hackett D. 1995. Safety and tolerance profile of venlafaxine.
International Clinical Psychopharmacology,, 10 (Suppl.2), 15-20.
Donoghue, J. & Hylan, T.R. 2001. Antidepressant use in clinical practice;
efficacy versus effectiveness. British Journal of Psychiatry, 179 (Suppl.42),
9-17.
Dwyer, M. & Byrne, G.J. 2000. Disruptive vocalisation and depression in
older nursing home residents. International Psycho geriatrics, 12, 463-471.
Einarson, T.R., Arikian, S.R,. Casciano, J. & Doyle, J.J. 1999. Comparison
of extended release Venlafaxine, selective serotonin re-uptake inhibitors,
and tricyclic antidepressants in the treatment of depression: a metaanalysis
of randomised controlled trials. Clinical Therapeutics, 21, 296-308.
Emptage, R.E., Semla, T.P., Gonzales, L. & Larouche, M. 1996.
Depression in the medically ill elderly: A focus on methylphenidate. Annals
of Pharmacotherapy, 30(2), 151-157.
Everybody's Business. Integrated mental health service for older adults: a
service development guide 2005. Care Services Improvement Partnership/
Department of Health, London: www.everybodysbusiness.org.uk.
Fahy, S. & Lawlor BA. 2001. Discontinuation of lithium augmentation in an
elderly cohort. International Journal of Geriatric Psychiatry, 16(10), 1004-
1009.
Flint, A.J. 2002. Treatment-resistant depression in late life. CNS
Spectrums, 7(10), 733-738.
Flint, A.J. & Rifat, S.L. 1996. The effect of sequential antidepressant
treatment on geriatric depression. Journal of Affective Disorders, 36, 95-
105.
Flint, A J. 1992. The optimum duration of antidepressant treatment in the
elderly. International Journal of Geriatric Psychiatry, 7, 617-619.
Flint, A.J., Rifat, S.L. 1994. A prospective study of lithium augmentation in
antidepressant-resistant geriatric depression. Journal of Clinical
Psychopharmacology, 14, 353-356.
Furukawa, T., McGuire, H. & Barbui C 2004. Low dosage tricyclic
antidepressants for depression. Cochrane Review 3,.Georgotas, A. & McCue, R. 1989. The additional benefit of extending an
antidepressant trial past seven weeks in the depressed elderly.
International Journal of Geriatric Psychiatry, 4, 191-195.
Georgotas, A.M.R., Cooper, T. 1989. Factors affecting the delay of
antidepressant effect in responders to nortriptyline and phenelzine.
Psychiatry Research, 28, 1-9.
Glassman, A.H., O’Connor, C.M., Califf, R.M., Swedberg, K. et al. 2002.
Sertraline treatment of major depression in patients with acute MI or
unstable angina. Journal of the American Medical Association, 288(6), 701-
709.
Guaiana, G., Barbui, C. & Hotopf, M. 2004. Amitriptyline versus other types
of pharmacotherapy for depression. Cochrane Review 3.
Guscott, R. & Grof. P. 1991. The clinical meaning of refractory depression:
a review for the clinician. American Journal of Psychiatry, 148, 695-704.
Hale, A, Proctor, A.W. & Bridges, P.K. 1987. Clomipramine, tryptophan and
lithium in combination for resistant endogenous depression seven case
studies. British Journal of Psychiatry, 151, 213-217.
Halikas, J.A. 1995. Org 3770 (mirtazapine) versus trazodone; a placebo
controlled trial in depressed elderly patients. Human Psychopharmacology,;
10, 125-133.
Hindmarch, I. 2001. Expanding the horizons of depression; beyond the
monoamine hypothesis. Human Psychopharmacology, 16(3), 203-218.
Hoencamp, E., Haffmans, P.M.J., Dijken, W.A., et al. 2000. Lithium
augmentation of venlafaxine: an open-label trial. Journal of Clinical
Psychopharmacology, 20, 538-543.
Hoyberg, O.J., Maragakis, B., & Mullin, J. et al. 1996. A double-blind multicentre
comparison of mirtazapine and amitriptyline in elderly depressed
patients. Acta Psychiatrica Scandinavica, 93, 184-190.
Hudson, J.I., Wohlreich, M.M., Kajdasz, D.K. et al. 2005. Safety and
tolerability of duloxetine in the treatment of major depressive disorder; an
analysis of pooled data from eight placebo-controlled clinical trials. Human
Psychopharmacology, 20, 327-341.
Jonas, B.S. & Mussolino, M. E. 2000. Symptoms of depression as a
prospective risk factor for stroke. Psychosomatic Medicine, 62, 463-471.
Kalayam, B. & Alexopoulos, G.S. 1999. Prefrontal dysfunction and
treatment response in geriatric depression. Archives of General Psychiatry,
56(8), 713-718.
Katona, C., Bercoff, E., Chiu, E., Tack, P., Versiani, M. & Woelk, H. 1999.
Reboxetine versus imipramine in the treatment of elderly patients with
depressive disorders; a double-blind randomised trial. Journal of Affective
Disorders, 55, 203-213.Kirby, D., Harrigun, S. & Ames, D. 2002. Hyponatraemia in elderly
psychiatric patients treated with SSRIs and venlafaxine: a retrospective
controlled study in an in-patient unit. International Journal of Geriatric
Psychiatry,; 17, 231-7.
Koenig, H.G., Meador, K. G., Cohen, H.J. & Blazer, D. 1988. Depression in
elderly hospitalised patients with medical illness. Archives of Internal
Medicine, 148, 1929-1936.
Krystal, A.D., Coffey, C.E., Weiner, R.D. & Holsinger, T. 1998. Changes in
seizure threshold over the course of electroconvulsive therapy affect
therapeutic response and are detected by ictal EEG ratings. Journal of
Neuropsychiatry & Clinical Neurosciences, 10(2), 178-186.
Laidlaw, K, Thompson, L.W., Dick-Siskin, L. & Gallagher-Thompson, D.
2003. Cognitive Behaviour Therapy with Old People. John Wiley & Sons,
Chichester
Li, Y.S., Meyer, J.S. & Thornby, J. 2001. Longitudinal follow-up of
depressive symptoms among normal versus cognitively impaired elderly.
International Journal of Geriatric Psychiatry, 16(7), 718-727.
Mahapatra, S.N. & Hackett, D. 1997. A randomised, double-blind, parallelgroup
comparison of venlafaxine and dothiepin in geriatric patients with
major depression. International Journal of Clinical Practice, 51(4). 209-213.
Mendlewicz, J. 1995. Pharmacologic profile and efficacy of venlafaxine.
International Clinical Psychopharmacology, 10 (Suppl.2), 5-13.
Mendlewicz, J. 2001. Optimising antidepressant use in clinical practice;
towards criteria for antidepressant selection. British Journal of Psychiatry,
179 (Suppl. 42), 1-3.
Mittman, N., Herrmann, N., Einarson, T.R. et al. 1997. The efficacy, safety
and tolerability of antidepressants in late life depression: a meta-analysis.
Journal of Affective Disorders, 46, 191-217.
Moreno, F.A., Gelenberg, A.J., Bachar, K. & Delgado, P.L. 1997. Pindolol
augmentation of treatment-resistant depressed patients. Journal of Clinical
Psychiatry, 58(10), 437-439.
Morishita, S., Aoki, S. 1999. Clonazepam in the treatment of prolonged
depression. Journal of Affective Disorders, 53(3), 275-278.
Mottram, P, Wilson, K.C.M., Ashworth, L. & Abou-Saleh, M. 2002. The
clinical profile of older patients' response to antidepressants - an open trial
of sertraline. International Journal of Geriatric Psychiatry, 17, 574-578.
Navarro, V., Gasto, C., Torres, .X, Marcos, T. & Pintos, L. 2001. Citalopram
versus nortriptyline in late-life depression: A 12 week randomized singleblind
study. Acta Psychiatrica Scandinavica, 103(6), 435-440.
National Institute for Clinical Excellence 2004. Depression: Management of
Depression in Primary and Secondary Care, Clinical Guideline 23,
December, London.Nelson, J.C., Wohlreich, M.M., Mallinckrodt, C.H. et al. 2005. Duloxetine for
the treatment of major depressive disorder in older people. American
Journal of Geriatric Psychiatry, 13(3), 227-235.
Nierenberg, A.A., Feighner, J.P., Rudolph, R. et al. 1994. Venlafaxine for
treatment-resistant unipolar depression. Journal of Clinical
Psychopharmacology, 14, 419-423.
2000. Neuroimaging in dementia and
Old Age Depression Interest Group 1993. How long should the elderly take
antidepressants? A double-blind placebo-controlled study of
continuation/prophylaxis therapy with dothiepin. British Journal of
Psychiatry, 162, 75-182.
Oslin, D.W., Have, T.R.T. & Streim, J.E. et al.2003. Probing the safety of
medications in the frail elderly; evidence from a randomised clinical trial of
sertraline and venlafaxine in depressed nursing home residents. Journal of
Clinical Psychiatry, 64(8), 875-882.
Penninx, B.W., Deeg, D.J., van Eijk, J.T. et al. 2000. Changes in
depression and physical decline in older adults; a longitudinal perspective.
Journal of Affective Disorders, 61, 1-12.
Pridmore, S. & Turnier, S.Y. 2004. Medication options in the treatment of
treatment-resistant depression. Australian and New Zealand Journal of
Psychiatry, 38(4), 219-225.
Rapaport,M.H., Schneider, L.S., Dunner, D.L. et al. 2003. Efficacy of
controlled-release paroxetine in the treatment of late-life depression.
Journal of Clinical Psychiatry, 64(9), 1065-1074.
Renwick, R.A. 1985. Treatment resistant depression. Psychiatric Journal of
University of Ottawa, 46, 576-584.
Reynolds, C.F., III, Perel, J.M. & Frank E, et al. 1999. Three-year outcomes
of maintenance nortriptyline treatment in late-life depression: a study of two
fixed plasma levels. American Journal of Psychiatry, 156(8), 1177-1181.
Roth, M., Montjoy, C. & Amrein, R. 1996. Moclobemide in elderly patients
with cognitive decline and depression: an international double–blind trial,
placebo-controlled trial. British Journal of Psychiatry, 168(2), 149-157.
Schatzberg, A.F., Kremer, C., Rodrigues, H.E., Murphy & G.M. et al. 2002.
Double-blind, randomised comparison of mirtazapine and paroxetine in
elderly depressed patients. American Journal of Geriatric Psychiatry, 10(5),
541-550.
Shapira, B., Tub,i N., Drexler, H., Lidsky, D., Calev, A. & Lerer, B. 1998.
Cost and benefit in the choice of ECT schedule. Twice versus three times
weekly ECT. British Journal of Psychiatry, 172, 44-48.Sheikh, J..I, Cassidy, E.L., Doraiswamy, P.M. et al. 2004. Efficacy, safety
and tolerability of sertraline in patients with late-life depression. Journal of
the American Geriatrics Society, 52(1). 86-92.
Smith, D., Dempster, C., Glanvile, J. et al. 2002. Efficacy and tolerability of
venlafaxine compared with selective serotonin reuptake inhibitors and other
antidepressants; a meta-analysis. British Journal of Psychiatry, 180, 396-
404.
Stah,l S. & Briley, M. 2004. Understanding pain in depression. Human
Psychopharmacology, 19, S9-S13.
Stahl, S 2000. Essential Psychopharmacology; Neuroscientific Basis and
Practical Applications. Second Edition, Cambridge, CUP.
Stahl, S.M. 1998. Basic psychopharmacology of antidepressants part 2:
oestrogen as an adjunct to antidepressant treatment. Journal of Clinical
Psychiatry, 59(4), 15-24.
Thase, M.E. & Rush, A.J. 1997. Treatment resistant depression. In: Bloom
FEaKD, editor. Psychopharmacology: The Fourth Generation of Progress.
New York: Raven Press, 1081-1215.
Thase, M.E., Entsuah, R. & Rudolph, R.L. 2001. Remission rates during
treatment with venlafaxine or selective serotonin reuptake inhibitors. British
Journal of Psychiatry, 178, 234-241.
Timmer, .CL., Paanakker, J.E. & van Hal, H.J.M. 1996. Pharmacokinetics
of mirtazapine from orally administered tablets: influence of age, gender
and treatment regimen. Human Psychopharmacology, 11, 497-509.
Tourigny-Rivard, M.F. 1997. Pharmacotherapy of affective disorders in old
age. Canadian Journal of Psychiatry, 42 (1)

Depositing User: Sara Taylor
Date Deposited: 17 Apr 2008 14:02
Last Modified: 16 Aug 2013 12:19
URI: http://eprints.hud.ac.uk/id/eprint/665

Downloads

Downloads per month over past year

Repository Staff Only: item control page

View Item View Item

University of Huddersfield, Queensgate, Huddersfield, HD1 3DH Copyright and Disclaimer All rights reserved ©